If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising ...

Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Prostate cancer is one of the most common cancers affecting men, particularly those over 50. The disease can often grow silently in its early stages, with few obvious symptoms. Because of this, early ...

Former President Joe Biden's office announced Sunday that he has been diagnosed with an "aggressive" form of prostate cancer, which has spread to his bones. But it said the cancer appears to be ...

In the month of October, many organizations use the color pink to raise awareness for breast cancer. Women are encouraged to do regular home exams and to attend their annual mammograms. For men, ...

Editor's note: second of two parts; read part one here.. In the first part of our series, we described how PSA is used as a screening tool to help detect prostate cancer in men who don't have symptoms ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Because most of the major risk factors are beyond your control, there’s no proven way to truly reduce ...

Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...

Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.